COMMUNIQUÉS West-GlobeNewswire

Safe Legal Steroid Alternatives: CrazyBulk Announces 2026 Legal Steroids For Muscle Growth and Strength Available In USA
01/07/2026
Discover CrazyBulk's safe legal steroid alternatives designed to support muscle growth, bulking, cutting, strength, and bodybuilding with science-inspired formulas. New York City, July 01, 2026 (GLOBE NEWSWIRE) -- In [...]
Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform
01/07/2026
Commercial Launch Begins Company's First Consumer Revenue Stream, Bringing Science-Backed Women's Health Solutions Directly to Consumers SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE [...]
How Meaningful Work Supports Long-Term Sobriety
01/07/2026
San Diego-based Shoreline Recovery Center highlights the role employment plays in rebuilding confidence, purpose and stability following addiction treatment San Diego, CA, July 01, 2026 (GLOBE NEWSWIRE) -- For many [...]
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
01/07/2026
FDA feedback supports NewcelX’s planned development strategy for NCEL-101 in combination with Tegoprubart ZURICH, July 01, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical-stage regenerative [...]
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
01/07/2026
Issued 4,444,445 new ordinary shares Priced at €2.70 per share, representing a 14.15% discount on the five-day VWAP and a 12.68% discount to the June 30 closing price The transaction has been structured as a capital [...]
Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director
01/07/2026
Neil Gallagher, MD, PhD, joins with over 25 years clinical development experience, having contributed to multiple commercial therapeutics across haematology and oncology His appointment will strengthen Step Pharma’s [...]
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
01/07/2026
MALVERN, Pa., July 01, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
01/07/2026
Secures Global Framework for Composition-of-Matter and Method-of-Treatment Claims Covering Lead Program Ebstrocel for Epidermolysis Bullosa and Next-Generation Engineered Modalities Extending to 2045 BOCA RATON, Fla., [...]
BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches
01/07/2026
- Preferred equity investment led by Sixth Street and with participation from HealthCare Royalty, a business of KKR, with an initial conversion price of approximately $138 per share (more than 100% premium to Company’s [...]
Ocugen to Participate in Upcoming July Industry Conferences
01/07/2026
MALVERN, Pa., July 01, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2026
CLEVELAND, July 01, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences
01/07/2026
BEDFORD, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation [...]
Stryker to announce second quarter 2026 financial results
01/07/2026
Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026 , to discuss its second quarter 2026 financial results. The live [...]
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
01/07/2026
Independent DSMB identifies no safety concerns and recommends continuation of the clinical trial being conducted at the Icahn School of Medicine at Mount Sinai WASHINGTON, July 01, 2026 (GLOBE NEWSWIRE) -- 60 Degrees [...]
Harrow Announces Commercial Launch of BYOOVIZ® in the United States
01/07/2026
Expands Harrow's Growing Retina Portfolio with an Interchangeable Ranibizumab Biosimilar NASHVILLE, Tenn., July 01, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management [...]
Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics
01/07/2026
Seer's particle-based proteomics IP withstands challenges in both Europe and the United States REDWOOD CITY, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, [...]
Human Appeal supports Syrian farmers through new wheat supply chain project
01/07/2026
The initiative will help more than 1,000 farmers across northwest Syria rebuild livelihoods, strengthen food security and restore agricultural production as they return to their communities MISSION VIEJO, Calif., July [...]
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
01/07/2026
Medical Segment Momentum Accelerates, Posting 300% Growth Versus Q2 2025 Company to Showcase Technology at American Society of Pain & Neuroscience Conference in Miami Beach, July 16–18, Alongside Board Member and [...]
Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®
01/07/2026
-- Expands Patient Access to Non-Opioid Postsurgical Pain Management Across Outpatient Settings -- BRISBANE, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its [...]

Pages